Aliouat et al. 2019 (PRJNA521751)
General Details
Title | Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes |
---|---|
Organism | |
Number of Samples | 6 |
Release Date | 2019/02/11 00:00 |
Sequencing Types | |
Protocol Details |
Study Links
GWIPS-viz | Trips-Viz |
---|---|
Repository Details
SRA | SRP185496 |
---|---|
ENA | SRP185496 |
GEO | GSE126385 |
BioProject | PRJNA521751 |
Publication
Title | |
---|---|
Authors | Aliouat A, Hatin I, Bertin P, François P, Stierlé V, Namy O, Salhi S, Jean-Jean O |
Journal | RNA biology |
Publication Date | 2020 Feb |
Abstract | In addition to its role in translation termination, eRF3A has been implicated in the nonsense-mediated mRNA decay (NMD) pathway through its interaction with UPF1. NMD is a RNA quality control mechanism, which detects and degrades aberrant mRNAs as well as some normal transcripts including those that harbour upstream open reading frames in their 5' leader sequence. In this study, we used RNA-sequencing and ribosome profiling to perform a genome wide analysis of the effect of either eRF3A or UPF1 depletion in human cells. Our bioinformatics analyses allow to delineate the features of the transcripts controlled by eRF3A and UPF1 and to compare the effect of each of these factors on gene expression. We find that eRF3A and UPF1 have very different impacts on the human transcriptome, less than 250 transcripts being targeted by both factors. We show that eRF3A depletion globally derepresses the expression of mRNAs containing translated uORFs while UPF1 knockdown derepresses only the mRNAs harbouring uORFs with an AUG codon in an optimal context for translation initiation. Finally, we also find that eRF3A and UPF1 have opposite effects on ribosome protein gene expression. Together, our results provide important elements for understanding the impact of translation termination and NMD on the human transcriptome and reveal novel determinants of ribosome biogenesis regulation. |
PMC | PMC6973328 |
PMID | 31619139 |
DOI |
Run Accession | Study Accession | Scientific Name | Cell Line | Library Type | Treatment | GWIPS-viz | Trips-Viz | Reads | BAM | BigWig (F) | BigWig (R) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SRR8558080 | PRJNA521751 | Homo sapiens | HCT116 | Ribo-Seq | Cycloheximide | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
||
SRR8558081 | PRJNA521751 | Homo sapiens | HCT116 | Ribo-Seq | Cycloheximide | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
||
SRR8558082 | PRJNA521751 | Homo sapiens | HCT116 | Ribo-Seq | Cycloheximide | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
||
SRR8558083 | PRJNA521751 | Homo sapiens | HCT116 | Ribo-Seq | Cycloheximide | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
||
SRR8558084 | PRJNA521751 | Homo sapiens | HCT116 | Ribo-Seq | Cycloheximide | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
||
SRR8558085 | PRJNA521751 | Homo sapiens | HCT116 | Ribo-Seq | Cycloheximide | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
||
Run Accession | Study Accession | Scientific Name | Cell Line | Library Type | Treatment | GWIPS-viz | Trips-Viz | Reads | BAM | BigWig (F) | BigWig (R) |
ⓘ For more Information on the columns shown here see: About